Process View
Any process that activates or increases the frequency, rate, or extent of the production of molecular mediator of immune response.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "positive regulation of production of molecular mediator of immune response"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 1.000 | Fly | |
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.999 | ||
| RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.999 | ||
| TRAF1 | TNF receptor-associated factor 1 | 0.998 | Human | |
| NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 0.998 | Fly | |
| NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 0.998 | Fly | |
| IL4R | interleukin 4 receptor | 0.995 | Mouse | |
| NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.995 | Fly | |
| BIRC3 | baculoviral IAP repeat containing 3 | 0.987 | ||
| CD40 | CD40 molecule, TNF receptor superfamily member 5 | 0.983 | Mouse Rat | |
| REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 0.983 | Fly | |
| RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.975 | ||
| TRAF6 | TNF receptor-associated factor 6 | 0.966 | ||
| IKBKG | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma | 0.961 | ||
| TRAF3 | TNF receptor-associated factor 3 | 0.941 | Human | |
| IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.869 | Fly | |
| CASP1 | caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) | 0.853 | Fly | |
| NFKBIB | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta | 0.851 | Fly | |
| CCL2 | chemokine (C-C motif) ligand 2 | 0.677 | Human | |
| CCL4 | chemokine (C-C motif) ligand 4 | 0.675 | Human | |
| CCR5 | chemokine (C-C motif) receptor 5 | 0.653 | ||
| CHUK | conserved helix-loop-helix ubiquitous kinase | 0.627 | Fly | |
| TNFRSF13B | tumor necrosis factor receptor superfamily, member 13B | 0.553 | ||
| ICAM1 | intercellular adhesion molecule 1 | 0.519 | ||
| MAP3K14 | mitogen-activated protein kinase kinase kinase 14 | 0.514 | ||
| CRADD | CASP2 and RIPK1 domain containing adaptor with death domain | 0.496 | ||
| TRAF2 | TNF receptor-associated factor 2 | 0.463 | ||
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.459 | ||
| TIRAP | toll-interleukin 1 receptor (TIR) domain containing adaptor protein | 0.444 | ||
| BCL3 | B-cell CLL/lymphoma 3 | 0.425 | Fly | |
| SOX10 | SRY (sex determining region Y)-box 10 | 0.365 | ||
| MYD88 | myeloid differentiation primary response gene (88) | 0.347 | Fly | |
| IL2RG | interleukin 2 receptor, gamma | 0.318 | ||
| PAX3 | paired box 3 | 0.301 | ||
| CCL8 | chemokine (C-C motif) ligand 8 | 0.280 | Human | |
| CCR7 | chemokine (C-C motif) receptor 7 | 0.260 | ||
| ANGPT2 | angiopoietin 2 | 0.256 | ||
| CCL5 | chemokine (C-C motif) ligand 5 | 0.251 | Human | |
| GRAP2 | GRB2-related adaptor protein 2 | 0.204 | ||
| MAP3K7 | mitogen-activated protein kinase kinase kinase 7 | 0.202 | ||
| LY96 | lymphocyte antigen 96 | 0.187 | ||
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.181 | ||
| TNIP2 | TNFAIP3 interacting protein 2 | 0.165 | ||
| CCR1 | chemokine (C-C motif) receptor 1 | 0.144 | ||
| CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.138 | ||
| CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.138 | ||
| DPP4 | dipeptidyl-peptidase 4 | 0.133 | ||
| STAT6 | signal transducer and activator of transcription 6, interleukin-4 induced | 0.132 | Mouse | |
| CXCR4 | chemokine (C-X-C motif) receptor 4 | 0.128 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.117 | ||
| IL1B | interleukin 1, beta | 0.115 | ||
| TNF | tumor necrosis factor | 0.115 | ||
| CARD11 | caspase recruitment domain family, member 11 | 0.109 | ||
| CD80 | CD80 molecule | 0.094 | ||
| SQSTM1 | sequestosome 1 | 0.093 | ||
| TICAM2 | toll-like receptor adaptor molecule 2 | 0.091 | ||
| TLR2 | toll-like receptor 2 | 0.086 | ||
| NLRC4 | NLR family, CARD domain containing 4 | 0.086 | ||
| IL4 | interleukin 4 | 0.079 | Mouse | |
| OASL | 2'-5'-oligoadenylate synthetase-like | 0.075 | ||
| ANGPT1 | angiopoietin 1 | 0.072 | ||
| CCL13 | chemokine (C-C motif) ligand 13 | 0.066 | Human | |
| IRF1 | interferon regulatory factor 1 | 0.064 | ||
| TTR | transthyretin | 0.061 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.055 | ||
| SMURF1 | SMAD specific E3 ubiquitin protein ligase 1 | 0.054 | ||
| MAP3K8 | mitogen-activated protein kinase kinase kinase 8 | 0.053 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.050 | ||
| IDE | insulin-degrading enzyme | 0.047 | ||
| IL6R | interleukin 6 receptor | 0.045 | ||
| CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.044 | Human | |
| TNFAIP2 | tumor necrosis factor, alpha-induced protein 2 | 0.042 | ||
| LCP2 | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) | 0.042 | ||
| HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 | 0.041 | ||
| IL7R | interleukin 7 receptor | 0.041 | ||
| TAP1 | transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) | 0.040 | ||
| ENG | endoglin | 0.040 | ||
| IL8 | interleukin 8 | 0.040 | ||
| HLA-DPB1 | major histocompatibility complex, class II, DP beta 1 | 0.039 | ||
| HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 | 0.039 | ||
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.038 | ||
| PLEK | pleckstrin | 0.038 | ||
| TRAF5 | TNF receptor-associated factor 5 | 0.038 | Human | |
| BCL10 | B-cell CLL/lymphoma 10 | 0.035 | ||
| IKBKE | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon | 0.035 | ||
| IL10 | interleukin 10 | 0.034 | ||
| PTPN6 | protein tyrosine phosphatase, non-receptor type 6 | 0.034 | ||
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.033 | ||
| IRAK2 | interleukin-1 receptor-associated kinase 2 | 0.032 | ||
| CASP4 | caspase 4, apoptosis-related cysteine peptidase | 0.032 | Fly | |
| IRF4 | interferon regulatory factor 4 | 0.032 | ||
| CD83 | CD83 molecule | 0.031 | ||
| TNFSF13B | tumor necrosis factor (ligand) superfamily, member 13b | 0.031 | Human | |
| CD48 | CD48 molecule | 0.030 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.029 | ||
| ITGAL | integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) | 0.029 | ||
| CCR4 | chemokine (C-C motif) receptor 4 | 0.028 | ||
| TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 0.028 | ||
| CDC37 | cell division cycle 37 homolog (S. cerevisiae) | 0.028 | ||
| CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.027 | ||
| HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 and major histocompatibility complex, class II, DR beta 1 | 0.027 | ||
| SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.027 | ||
| IL6 | interleukin 6 (interferon, beta 2) | 0.027 | ||
| FZD1 | frizzled homolog 1 (Drosophila) | 0.026 | ||
| CCL3 | chemokine (C-C motif) ligand 3 | 0.026 | Human | |
| BCL2A1 | BCL2-related protein A1 | 0.025 | ||
| MALT1 | mucosa associated lymphoid tissue lymphoma translocation gene 1 | 0.024 | ||
| CD22 | CD22 molecule | 0.024 | ||
| IL1RN | interleukin 1 receptor antagonist | 0.024 | ||
| SEMA4D | sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D | 0.022 | ||
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.021 | ||
| TRAF3IP2 | TRAF3 interacting protein 2 | 0.021 | ||
| HLA-DQB1 | major histocompatibility complex, class II, DQ beta 1 | 0.020 | ||
| CCL1 | chemokine (C-C motif) ligand 1 | 0.020 | Human | |
| TP53BP1 | tumor protein p53 binding protein 1 | 0.019 | ||
| CCL7 | chemokine (C-C motif) ligand 7 | 0.018 | Human | |
| IFI44L | interferon-induced protein 44-like | 0.018 | ||
| NUMBL | numb homolog (Drosophila)-like | 0.018 | ||
| PSMB8 | proteasome (prosome, macropain) subunit, beta type, 8 (large multifunctional peptidase 7) | 0.018 | ||
| CCL19 | chemokine (C-C motif) ligand 19 | 0.018 | Human | |
| MAVS | mitochondrial antiviral signaling protein | 0.018 | ||
| SOD2 | superoxide dismutase 2, mitochondrial | 0.017 | ||
| ZNF512B | zinc finger protein 512B | 0.016 | ||
| GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | 0.016 | ||
| SLAMF1 | signaling lymphocytic activation molecule family member 1 | 0.016 | ||
| IL32 | interleukin 32 | 0.016 | ||
| ELF4 | E74-like factor 4 (ets domain transcription factor) | 0.015 | ||
| AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 0.015 | ||
| TNFRSF17 | tumor necrosis factor receptor superfamily, member 17 | 0.014 | ||
| ZC3H12A | zinc finger CCCH-type containing 12A | 0.014 | ||
| MX2 | myxovirus (influenza virus) resistance 2 (mouse) | 0.014 | ||
| IFNG | interferon, gamma | 0.013 | ||
| SYK | spleen tyrosine kinase | 0.013 | ||
| CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.013 | ||
| LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 0.012 | ||
| CSF1 | colony stimulating factor 1 (macrophage) | 0.012 | ||
| TYMP | thymidine phosphorylase | 0.012 | ||
| TIE1 | tyrosine kinase with immunoglobulin-like and EGF-like domains 1 | 0.012 | ||
| TRADD | TNFRSF1A-associated via death domain | 0.012 | ||
| IL13 | interleukin 13 | 0.011 | ||
| FSTL1 | follistatin-like 1 | 0.011 | ||
| CEBPA | CCAAT/enhancer binding protein (C/EBP), alpha | 0.011 | ||
| NCOA6 | nuclear receptor coactivator 6 | 0.011 | ||
| SMAD3 | SMAD family member 3 | 0.011 | ||
| IDO1 | indoleamine 2,3-dioxygenase 1 | 0.010 | ||
| TNFRSF11A | tumor necrosis factor receptor superfamily, member 11a, NFKB activator | 0.010 | ||
| IL15RA | interleukin 15 receptor, alpha | 0.010 | ||
| IL2RB | interleukin 2 receptor, beta | 0.010 | ||
| IL3 | interleukin 3 (colony-stimulating factor, multiple) | 0.010 |